Diabetes mellitus and electrolyte disorders.

Diabetic patients frequently develop a constellation of electrolyte disorders. These disturbances are particularly common in decompensated diabetics, especially in the context of diabetic ketoacidosis or nonketotic hyperglycemic hyperosmolar syndrome. These patients are markedly potassium-, magnesium- and phosphate-depleted. Diabetes mellitus (DM) is linked to both hypo- and hyper-natremia reflecting the coexistence of hyperglycemia-related mechanisms, which tend to change serum sodium to opposite directions. The most important causal factor of chronic hyperkalemia in diabetic individuals is the syndrome of hyporeninemic hypoaldosteronism. Impaired renal function, potassium-sparing drugs, hypertonicity and insulin deficiency are also involved in the development of hyperkalemia. This article provides an overview of the electrolyte disturbances occurring in DM and describes the underlying mechanisms. This insight should pave the way for pathophysiology-directed therapy, thus contributing to the avoidance of the several deleterious effects associated with electrolyte disorders and their treatment.

[1]  Susan E. Spratt,et al.  The Implementation and Evaluation of an Evidence-Based Protocol to Treat Diabetic Ketoacidosis: A Quality Improvement Study , 2014, Advanced emergency nursing journal.

[2]  M. Elisaf,et al.  Effects of glucagon-like peptide-1 receptor agonists on renal function. , 2013, World journal of diabetes.

[3]  L. Tarnow,et al.  Low dose spironolactone reduces blood pressure in patients with resistant hypertension and type 2 diabetes mellitus: a double blind randomized clinical trial , 2013, Journal of hypertension.

[4]  D. Kohan,et al.  Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control , 2013, Kidney international.

[5]  F. Barkas,et al.  Spurious Electrolyte Disorders: A Diagnostic Challenge for Clinicians , 2013, American Journal of Nephrology.

[6]  G. Funk,et al.  Hypernatremia in critically ill patients. , 2013, Journal of critical care.

[7]  N. Wright,et al.  Severe Hypercalcemia in Diabetic Ketoacidosis: A Case Report , 2013, Diabetes Care.

[8]  A. Hofman,et al.  Electrolyte disorders in community subjects: prevalence and risk factors. , 2013, The American journal of medicine.

[9]  G. Alexandridis,et al.  Hypomagnesemia in a department of internal medicine. , 2012, Magnesium research.

[10]  M. Hegazi,et al.  Central Pontine Myelinolysis in the Hyperosmolar Hyperglycaemic State , 2012, Medical Principles and Practice.

[11]  H. Rakugi,et al.  Hypomagnesemia in Type 2 Diabetic Nephropathy , 2012, Diabetes Care.

[12]  B. Epstein,et al.  Dapagliflozin: A Novel Sodium‐Glucose Cotransporter Type 2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus , 2012, Pharmacotherapy.

[13]  H. Milionis,et al.  Hyponatremia in patients with infectious diseases. , 2011, The Journal of infection.

[14]  K. He,et al.  Magnesium Intake and Risk of Type 2 Diabetes , 2011, Diabetes Care.

[15]  L. Palmer,et al.  Magnesium modulates ROMK channel-mediated potassium secretion. , 2010, Journal of the American Society of Nephrology : JASN.

[16]  C. Kesavadas,et al.  Clinical and functional outcome and factors predicting prognosis in osmotic demyelination syndrome (central pontine and/or extrapontine myelinolysis) in 25 patients , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[17]  H. Milionis,et al.  Medication-induced hypophosphatemia: a review. , 2010, QJM : monthly journal of the Association of Physicians.

[18]  M. Raebel,et al.  Diabetes and Drug-Associated Hyperkalemia: Effect of Potassium Monitoring , 2010, Journal of General Internal Medicine.

[19]  L. V. Van Gaal,et al.  Type 1 diabetes and autoimmune polyglandular syndrome: a clinical review. , 2009, The Netherlands journal of medicine.

[20]  A. Svare A patient presenting with symptomatic hypomagnesemia caused by metformin-induced diarrhoea: a case report , 2009, Cases journal.

[21]  H. Milionis,et al.  A review of drug-induced hypocalcemia , 2009, Journal of Bone and Mineral Metabolism.

[22]  J. N. Fisher,et al.  Hyperglycemic Crises in Adult Patients With Diabetes , 2009, Diabetes Care.

[23]  T. Erbas,et al.  Normal parathyroid hormone levels in a diabetic patient with parathyroid adenoma , 2009, Endocrine.

[24]  Tae-Jin Park,et al.  Magnesium Metabolism , 2008, Electrolyte & blood pressure : E & BP.

[25]  D. Berker,et al.  Severe hyponatremia due to rosiglitazone use in an elderly woman with diabetes mellitus: a rare cause of syndrome of inappropriate antidiuretic hormone secretion. , 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[26]  J. Kouba,et al.  Vitamin D and Diabetes , 2008, The Diabetes educator.

[27]  H. Milionis,et al.  Blood pressure drug therapy and electrolyte disturbances , 2008, International journal of clinical practice.

[28]  H. Milionis,et al.  A review of drug-induced hyponatremia. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[29]  S. Moe Disorders involving calcium, phosphorus, and magnesium. , 2008, Primary care.

[30]  J. Lado-Abeal,et al.  Hyperglycaemic Hyperosmolar Nonketotic State as a Cause of Low Gonadotrophin Levels in Postmenopausal Diabetic Women: A Role for Severe Hypernatraemia , 2007, Journal of neuroendocrinology.

[31]  M. Elisaf,et al.  Clinical and laboratory characteristics of hypernatraemia in an internal medicine clinic. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[32]  A. Kitabchi,et al.  Hyperglycemic Crises in Adult Patients With Diabetes: A Consensus Statement From the American Diabetes Association , 2007, Diabetes Care.

[33]  R. Zietse,et al.  Novel risk factors for hospital‐acquired hyponatraemia: a matched case–control study , 2007, Clinical endocrinology.

[34]  Jeffrey M. Miller,et al.  Hypomagnesemia in patients with type 2 diabetes. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[35]  M. Barbagallo,et al.  Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. , 2007, Archives of biochemistry and biophysics.

[36]  M. Elisaf,et al.  Therapeutic approach in patients with dysnatraemias. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[37]  A. Topaloğlu,et al.  Bone calcium changes during diabetic ketoacidosis: a comparison with lactic acidosis due to volume depletion. , 2005, Bone.

[38]  J. Miller,et al.  Lower serum magnesium levels are associated with more rapid decline of renal function in patients with diabetes mellitus type 2. , 2005, Clinical nephrology.

[39]  Haruo Nishimura,et al.  Central pontine and extrapontine myelinolysis associated with type 2 diabetic patient with hypokalemia. , 2005, Diabetes research and clinical practice.

[40]  R. S. Smith,et al.  A comparison of corrected serum calcium levels to ionized calcium levels among critically ill surgical patients. , 2005, American journal of surgery.

[41]  A. Chibalin,et al.  Insulin potentiates AVP-induced AQP2 expression in cultured renal collecting duct principal cells. , 2005, American journal of physiology. Renal physiology.

[42]  B. Palmer Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. , 2004, The New England journal of medicine.

[43]  G. Borretta,et al.  Derangement of glucose metabolism in hyperparathyroidism , 2003, Journal of endocrinological investigation.

[44]  J. Chiasson,et al.  Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[45]  W. H. Taylor,et al.  Coincident diabetes mellitus and primary hyperparathyroidism , 2001, Diabetes/metabolism research and reviews.

[46]  H. Milionis,et al.  Appropriate treatment of hypernatraemia in diabetic hyperglycaemic hyperosmolar syndrome , 2001, Journal of internal medicine.

[47]  L. Bankir,et al.  Vasopressin and Diabetes mellitus , 2001, Nephron.

[48]  M. Elisaf,et al.  Hyperosmolar nonketotic syndrome with hypernatremia: how can we monitor treatment? , 2000, Diabetes & metabolism.

[49]  D. Cucinotta,et al.  Serum Ionized Magnesium Levels in Type 2 Diabetic Patients with Microalbuminuria or Clinical Proteinuria , 2000, American Journal of Nephrology.

[50]  C. Wilcox,et al.  Metabolic and adverse effects of diuretics. , 1999, Seminars in nephrology.

[51]  R. Abbott,et al.  Hyponatremia: evaluating the correction factor for hyperglycemia. , 1999, The American journal of medicine.

[52]  P. Schuck,et al.  Magnesium and phosphorus , 1998, The Lancet.

[53]  J. Bauza,et al.  Reliability of serum magnesium values during diabetic ketoacidosis in children. , 1998, Boletin de la Asociacion Medica de Puerto Rico.

[54]  T. Berl,et al.  The hyponatremic patient: practical focus on therapy. , 1997, Journal of the American Society of Nephrology : JASN.

[55]  K. Siamopoulos,et al.  Acid-base and electrolyte disturbances in patients with diabetic ketoacidosis. , 1996, Diabetes research and clinical practice.

[56]  A. Kolasa,et al.  Regulation of the insulin-like growth factor system by acute acidosis. , 1996, Endocrinology.

[57]  Graham M Lord,et al.  Diabetes and rhabdomyolysis. A rare complication of a common disease. , 1993, BMJ.

[58]  P. Mcnair,et al.  Hypocalcemia and parathyroid hormone responsiveness in diabetes mellitus: a tri-sodium-citrate clamp study. , 1992, Acta endocrinologica.

[59]  J. Daugirdas,et al.  Asymptomatic, nonketotic, severe hyperglycemia with hyponatremia. , 1990, Archives of internal medicine.

[60]  A. Arieff,et al.  Fatal central diabetes mellitus and insipidus resulting from untreated hyponatremia: a new syndrome. , 1990, Annals of internal medicine.

[61]  W. Waldhäusl,et al.  Effect of hyperosmolality on basal and hormone‐stimulated hepatic glucose metabolism in vitro , 1989, European journal of clinical investigation.

[62]  W. Waldhäusl,et al.  Detrimental effect of hyperosmolality on insulin-stimulated glucose metabolism in adipose and muscle tissue in vitro. , 1988, Biochemical medicine and metabolic biology.

[63]  G. Paolisso,et al.  Insulin induces opposite changes in plasma and erythrocyte magnesium concentrations in normal man , 1986, Diabetologia.

[64]  G. Eknoyan,et al.  Determinants of Plasma Potassium Levels in Diabetic Ketoacidosis , 1986, Medicine.

[65]  P. Cadnapaphornchai,et al.  Dynamic changes in serum phosphorus levels in diabetic ketoacidosis. , 1985, The American journal of medicine.

[66]  M H Kroll,et al.  Relationships between magnesium and protein concentrations in serum. , 1985, Clinical chemistry.

[67]  R. DeFronzo,et al.  Impairment of Insulin-mediated Glucose Metabolism by Hyperosmolality in Man , 1983, Diabetes.

[68]  T. Kadowaki,et al.  Chlorpropamide-induced Hyponatremia: Incidence and Risk Factors , 1983, Diabetes Care.

[69]  A. Kitabchi,et al.  A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. , 1983, The Journal of clinical endocrinology and metabolism.

[70]  L. Kerp,et al.  Regulation of Serum Potassium During Insulin-induced Hypoglycemia , 1982, Diabetes.

[71]  K. Minaker,et al.  Potassium homeostasis during hyperinsulinemia: effect of insulin level, beta-blockade, and age. , 1982, The American journal of physiology.

[72]  G. Eknoyan,et al.  Phosphate therapy in diabetic ketoacidosis. , 1982, Archives of internal medicine.

[73]  N. Madias,et al.  Changes in plasma potassium concentration during acute acid-base disturbances. , 1981, The American journal of medicine.

[74]  U. Keller,et al.  Prevention of Hypophosphatemia by Phosphate Infusion During Treatment of Diabetic Ketoacidosis and Hyperosmolar Coma , 1980, Diabetes.

[75]  L. Phillips,et al.  Diabetic ketoacidosis: Induction of hypocalcemia and hypomagnesemia by phosphate therapy , 1979 .

[76]  H Lund-Andersen,et al.  Transport of glucose from blood to brain. , 1979, Physiological reviews.

[77]  R. Kreisberg,et al.  Diabetic ketoacidosis: new concepts and trends in pathogenesis and treatment. , 1978, Annals of internal medicine.

[78]  R. Kreisberg,et al.  Phosphorus deficiency and hypophosphatemia. , 1977, Hospital practice.

[79]  A. Moses,et al.  Diuretic action of three sulfonylurea drugs. , 1973, Annals of internal medicine.

[80]  P. Beigelman Potassium in severe diabetic ketoacidosis. , 1973, The American journal of medicine.

[81]  C. Boitard,et al.  Hyperparathyroidism in a patient with autoimmune polyglandular syndrome. , 2008, Internal medicine.

[82]  E. Balint,et al.  Glucose-induced inhibition of in vitro bone mineralization. , 2001, Bone.

[83]  M. Matsumura,et al.  Electrolyte disorders following massive insulin overdose in a patient with type 2 diabetes. , 2000, Internal medicine.

[84]  P. Singhal,et al.  Determinants of rhabdomyolysis in the diabetic state. , 1991, American journal of nephrology.

[85]  J. Uribarri,et al.  Hyperkalemia in diabetes mellitus. , 1990, The Journal of diabetic complications.

[86]  E. Heidbreder,et al.  Diminished parathyroid gland responsiveness to hypocalcemia in diabetic patients with uremia. , 1986, Nephron.

[87]  D. Batlle,et al.  Hyperkalemia and renal insufficiency: role of selective aldosterone deficiency and tubular unresponsiveness to aldosterone. , 1981, American journal of nephrology.

[88]  F. B. Davis,et al.  Water metabolism in diabetes mellitus. , 1981, The American journal of medicine.

[89]  C. Christiansen,et al.  Hypoparathyroidism in diabetes mellitus. , 1981, Acta endocrinologica.

[90]  R. DeFronzo,et al.  Hyperkalemia and hyporeninemic hypoaldosteronism. , 1980, Kidney international.

[91]  A. Mehta,et al.  Pathogenesis and treatment , 2022 .